Halberd Corp.

Develop extra-corporeal treatments of disease

Recent News

  • Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure

    Jackson Center, Pennsylvania--(Newsfile Corp. - October 20, 2021) - Halberd Corporation's (OTC Pink: HALB) ongoing research into discovering treatments/cures for PTSD, Alzheimer's Disease, and other neurodegenerative diseases has led to a potential breakthrough in the battle against obesity. Research has indicated inflammatory cytokines present in the Cerebral Spinal Fluid (CSF) of neurodegenerative disease patients are also found in the blood of those suffering from obesity.Halberd's patent-pending extracorporeal treatment for removing the disease antigens, excess proteins and cytokines from CSF...

    2021-10-20 8:00 AM EDT
  • Halberd and GTX Corp Sign Scientific Collaboration and Reseller Agreement

    Jackson Center, Pennsylvania--(Newsfile Corp. - October 12, 2021) - Halberd Corporation (OTC Pink: HALB) and GTX Corp (OTC Pink: GTXO) have agreed to work together on various neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, PTSD/CTE (Chronic Traumatic Encephalopathy)/ Traumatic Brain Injury), among others. These diseases are prevalent among seniors, active duty and veteran soldiers, participants in contact sports and millions of people in the general population. Halberd and GTX intend to work together to utilize their combined...

    2021-10-12 1:59 PM EDT
  • Halberd Corporation CEO Letter

    Jackson Center, Pennsylvania--(Newsfile Corp. - October 7, 2021) - Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK: HALB) This past quarter, Halberd has made some very significant and unparalleled achievements developing treatments for neurodegenerative diseases, such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.As reported in the last quarterly update, our research led us to investigate RF (Radio Frequency) and laser exposure, as the two patent-pending extracorporeal methods to eliminate targeted...

    2021-10-07 8:00 AM EDT
  • Halberd's VITASHIELDMAX(TM) Immunity Support Product Available on Amazon

    Jackson Center, Pennsylvania--(Newsfile Corp. - October 5, 2021) - Halberd Corporation (OTC Pink: HALB) announced that its nutraceutical immune support product, VitaShieldMaxTM, is now available through Amazon, in addition to its availability through Halberd's website at www.vitashieldmax.com.William A. Hartman, Halberd's Chairman, President & CEO, stated, "We are pleased that our product will now also be available through Amazon, and will be able to reach virtually anyone in need of immunity support to maintain their body's health and resistance to diseases....

    2021-10-05 8:00 AM EDT
  • Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement

    Jackson Center, Pennsylvania--(Newsfile Corp. - September 22, 2021) - Halberd Corp. (OTC Pink: HALB) and heliosDx, a wholly owned company of Rush Net, Inc., an Alpharetta, GA company, announce a Scientific Collaboration Agreement to explore synergies and opportunities mutually beneficial to both companies. A major objective of the agreement is to develop accurate and reliable diagnostic methods by sharing innovative ideas and technologies that will provide the foundation for more effective disease management. Halberd Corporation had been searching...

    2021-09-22 8:00 AM EDT
  • Halberd's Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN

    Jackson Center, Pennsylvania--(Newsfile Corp. - August 16, 2021) - Halberd Corporation's (OTC Pink: HALB) research at Youngstown State University (YSU) caught the attention of Youngstown, OH TV news station, WKBN, a CBS affiliate. The station's 5:00PM newscast on Friday, August 13, 2021, included a segment on Halberd's on-going research and testing of its groundbreaking, patent protected technology at YSU, which could revolutionize disease treatment worldwide as, reported by Dave Sess. Watch the news segment and read the entire news...

    2021-08-16 8:00 AM EDT
  • Halberd Corporation Adds Blood-Borne Disease Treatment Capability with Addition of Noted Nephrologist

    Jackson Center, Pennsylvania--(Newsfile Corp. - August 11, 2021) - Halberd Corporation (OTC Pink: HALB) today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board. Dr. Kronfol is certified by the American Board of Internal Medicine and retired in 2019 as Adjunct Clinical Professor from the William Carey University College of Osteopathic Medicine. Among many other notable accomplishments, Dr. Kronfol served as Medical Director- Renal Care Group/Fresenius Kidney Cat Lake Village, AR from...

    2021-08-11 8:00 AM EDT
  • Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped

    Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-MaxTM, has been shipped! With COVID-19 cases back on the rise fueled by the Delta Variant, this "Immunity Support Nutraceutical Product" is arriving at the right time.William A. Hartman, Halberd's Chairman, President & CEO, stated, "We will shortly begin selling Vita-Shield-MaxTM and will be releasing details on purchasing our product in the near future, once we have the product in inventory."Halberd Corporation released a...

    2021-08-09 8:00 AM EDT